Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis

doi:10.4251/wjgo.v13.i5.424

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 5

This Article

(292)

(323)

(0)

(19)

(5)

(2)

(5482)

(10)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Retrospective Study

World J Gastrointest Oncol. May 15, 2021; 13(5): 424-439
Published online May 15, 2021. doi: 10.4251/wjgo.v13.i5.424

Table 6 Multivariate analysis of independent prognostic factors for the survival of patients after the liver resection surgery for hepatocellular carcinoma

	HR	95%CI	P value
Age (yr)	1.02	0.96-1.08	0.493
Preoperative MELD score	1.37	1.16-1.62	< 0.001^c
Preoperative AFP (ng/mL)	1.001	1-1.002	0.08
BCLC stage
0	Reference	Reference	0.757
A	0.59	0.12-2.91
B	0.45	0.06-3.65
PHLF grade
Absent	Reference	Reference	< 0.001^c
A	2.33	0.59-9.24
B	3.15	1.11-8.95
C	373.41	66.23-2105.43
Postoperative MELD score > 10	1.03	0.39-2.67	0.958
Postoperative decompensation	2.03	0.64-6.46	0.23
HCC recurrence	11.67	4.19-32.52	< 0.001^c

^cP < 0.001.

AFP: alpha-fetoprotein; BCLC: Barcelona clinic liver cancer; CI: Confidence interval; HCC: Hepatocellular carcinoma; HR: Hazard ratio; MELD: Model for end-stage liver disease; PHLF: Post-hepatectomy liver failure.

Full Size Table

Citation: Elshaarawy O, Aman A, Zakaria HM, Zakareya T, Gomaa A, Elshimi E, Abdelsameea E. Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis. World J Gastrointest Oncol 2021; 13(5): 424-439
URL: https://www.wjgnet.com/1948-5204/full/v13/i5/424.htm
DOI: https://dx.doi.org/10.4251/wjgo.v13.i5.424

Elshaarawy O, Aman A, Zakaria HM, Zakareya T, Gomaa A, Elshimi E, Abdelsameea E. Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis. World J Gastrointest Oncol 2021; 13(5): 424-439 [PMID: 34040703 DOI: 10.4251/wjgo.v13.i5.424]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.